Business
Rip Ballou, MD, VP & Head, GSK Global Vaccines US R&D Center and BHI President & CEO Rich Bendis discuss GSK’s move to the BioHealth Capital Region, their Vaccines Portfolio/Future, and the importance of succeeding in the industry today.
More Episodes
Eric Richman, Gain Therapeutics (EP.85)
2021-04-30
2021-04-30
John Mumm, Deka BioSciences (EP.81)
2021-02-22
2021-02-22
Troy A LeMaile-Stovall, TEDCO (EP.80)
2021-02-10
2021-02-10
Ron Piervincenzi, Ph.D., USP (EP.77)
2021-01-19
2021-01-19
Stu Solomon, Connected DMV (EP.74)
2020-12-07
2020-12-07
Dr. Carol Nacy, Sequella (EP.73)
2020-11-23
2020-11-23
Praduman “PJ” Jain, Vibrent Health (EP.72)
2020-11-09
2020-11-09
Scott Carmer, NexImmune (EP.71)
2020-10-26
2020-10-26
Justin Yang, BARDA (EP.69)
2020-10-14
2020-10-14
John Trizzino, Novavax (EP.66)
2020-09-28
2020-09-28
Get this podcast on your
phone, FREE
